Magnesium, an essential factor in the pathogenesis and therapy of diseases of civilization
Schaumann, E.; Bergmann, W.
Zeitschrift für die Gesamte Hygiene und ihre Grenzgebiete 30(2): 84-87
1984
ISSN/ISBN: 0049-8610 PMID: 6711060 Document Number: 229835
Document emailed within 1 workday
Related Documents
Ditmar, R.; Steidl, L. 1987: The importance of magnesium in orthopedics. IV. the role of magnesium deficiency in the pathogenesis of osteoarticular diseases Acta Chirurgiae Orthopaedicae et Traumatologiae Cechoslovaca 54(5): 385-3991983: Pathogenesis, diagnosis and therapy of ulcer diseases. 6. Therapy. Pharmacologic principles and antacid therapy Die Medizinische Welt 34(47): 14-18
Betlejewski, S.ła. 2007: Social diseases, civilization diseases or lifestyle diseases? Wiadomosci Lekarskie 60(9-10): 489-492
Dimitriu, C.G.; Zeană, C. 1971: Significance of the immunological factor in the pathogenesis of kidney diseases Medicina Interna 23(8): 959-967
Cherkasov, S.V. 1983: On the concept of "diseases of civilization" Vestnik Akademii Meditsinskikh Nauk SSSR 7: 62-65
Egido, J.; Gómez-Chiarri, M.; Ortíz, A.; Bustos, C.; Alonso, J.; Gómez-Guerrero, C.; Gómez-Garre, D.; López-Armada, M.J.; Plaza, J.; Gonzalez, E. 1993: Role of tumor necrosis factor-alpha in the pathogenesis of glomerular diseases Kidney International. Suppl 39: S59-S64
Perskidskiĭ, I.V.; Barshteĭn, I.A. 1992: Biological manifestations of the tumor necrosis factor effect and its role in the pathogenesis of various diseases Arkhiv Patologii 54(2): 5-10
Lindeberg, S. 1989: Is civilization a presumption for the development of cardiovascular diseases? Lakartidningen 86(26-27): 2442-2443
1998: New findings on the pathogenesis and therapy of inflammatory diseases of the bronchial system Der Internist 39(1 Suppl Neues Zur): 1-8
Sikter, A.ás.; Faludi, G.áb.; Rihmer, Z.án. 2009: The role of carbon dioxide (and intracellular pH) in the pathomechanism of several mental disorders. Are the diseases of civilization caused by learnt behaviour, not the stress itself? Neuropsychopharmacologia Hungarica: a Magyar Pszichofarmakologiai Egyesulet Lapja 11(3): 161-173
Buemi, M.; Corica, F.; Squadrito, F.; Ceruso, D.; Frisina, N. 1988: Plasma and erythrocyte magnesium concentrations in essential arterial hypertension Kidney International. Suppl 25: S14-S15
Rayssiguier, Y. 1984: Role of magnesium and potassium in the pathogenesis of arteriosclerosis Magnesium 3(4-6): 226-238
Kowalczyk, J.; Pasyk, S.ła. 2002: Vascular endothelial growth factor and its application in therapy of cardiovascular diseases Polski Merkuriusz Lekarski: Organ Polskiego Towarzystwa Lekarskiego 13(73): 74-78
Lehr, D.; Chau, R.; Irene, S. 1975: Possible role of magnesium loss in the pathogenesis of myocardial fiber necrosis Recent Advances in Studies on Cardiac Structure and Metabolism 6: 95-109
García Zozaya, J.L.; Padilla Viloria, M. 1997: Alterations of calcium, magnesium, and zinc in essential hypertension:their relation to the renin-angiotensin-aldosterone system Investigacion Clinica 38(Suppl 2): 27-40
Kozielec, T.; Sałacka, A.; Radomska, K.; Strecker, D.; Durska, G. 2001: The influence of magnesium supplementation on magnesium and calcium concentrations in hair of children with magnesium shortage Magnesium Research 14(1-2): 33-38
Binet, P.; Miocque, M.; Pechery, C.; Roux, M.; Rinjard, P. 1978: Comparative corrective effect of magnesium 2-pyrrolidone carboxylate and magnesium chloride on skin and hematological disorders in experimental magnesium deficiency in the rat Therapie 33(4): 491-500
Ooguri, K. 1979: Pathogenesis of essential hypertension with low renin Nihon Jinzo Gakkai Shi 21(2): 123-134
Girolomoni, G.; Pastore, S.; Albanesi, C.; Cavani, A. 2002: Targeting tumor necrosis factor-alpha as a potential therapy in inflammatory skin diseases Current Opinion in Investigational Drugs 3(11): 1590-1595
Perosa, L.; Pirrelli, A. 1974: Experimental perspectives on the pathogenesis of essential arterial hypertension Recenti Progressi in Medicina 57(6): 503-514